Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Use of omalizumab in the treatment of food allergy and anaphylaxis.

Lieberman JA, Chehade M.

Curr Allergy Asthma Rep. 2013 Feb;13(1):78-84. doi: 10.1007/s11882-012-0316-x. Review.

PMID:
23065311
2.

Omalizumab in children.

Licari A, Marseglia A, Caimmi S, Castagnoli R, Foiadelli T, Barberi S, Marseglia GL.

Paediatr Drugs. 2014 Dec;16(6):491-502. doi: 10.1007/s40272-014-0107-z. Review.

3.

Anti-IgE--emerging opportunities for Omalizumab.

Babu KS, Polosa R, Morjaria JB.

Expert Opin Biol Ther. 2013 May;13(5):765-77. doi: 10.1517/14712598.2013.782391. Epub 2013 Mar 22. Review.

PMID:
23517576
4.

Omalizumab and hypersensitivity reactions.

Shankar T, Petrov AA.

Curr Opin Allergy Clin Immunol. 2013 Feb;13(1):19-24. doi: 10.1097/ACI.0b013e32835bf3f5. Review.

PMID:
23242113
5.

Omalizumab, an anti-immunoglobulin E antibody: state of the art.

Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E.

Drug Des Devel Ther. 2014 Feb 7;8:197-207. doi: 10.2147/DDDT.S49409. eCollection 2014.

6.

Anaphylaxis to vapors of roasting chicken controlled by omalizumab.

Barnig C, Hilger C, Muti D, Blaumeiser M, Purohit A, Hentges F, de Blay F.

J Investig Allergol Clin Immunol. 2012;22(6):439-40. No abstract available.

7.

Nonallergen-specific treatments for food allergy.

Lieberman JA, Wang J.

Curr Opin Allergy Clin Immunol. 2012 Jun;12(3):293-301. doi: 10.1097/ACI.0b013e3283534cf8. Review.

8.

Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.

Palgan K, Bartuzi Z, Gotz-Zbikowska M.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):109-12.

PMID:
24674685
9.

Omalizumab in allergic diseases, a recent review.

Vichyanond P.

Asian Pac J Allergy Immunol. 2011 Sep;29(3):209-19. Review.

PMID:
22053590
10.

The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology.

Mauro M, Incorvaia C, Formigoni C, Elia R, Russello M, Pellegrino D.

Panminerva Med. 2012 Dec;54(4):305-12. Review.

PMID:
23123583
11.

Effects of omalizumab in patients with food allergy.

Rafi A, Do LT, Katz R, Sheinkopf LE, Simons CW, Klaustermeyer W.

Allergy Asthma Proc. 2010 Jan-Feb;31(1):76-83. doi: 10.2500/aap.2010.31.3304.

PMID:
20167148
12.

Omalizumab in the treatment of eosinophilic esophagitis and food allergy.

Rocha R, Vitor AB, Trindade E, Lima R, Tavares M, Lopes J, Dias JA.

Eur J Pediatr. 2011 Nov;170(11):1471-4. doi: 10.1007/s00431-011-1540-4. Epub 2011 Aug 2.

PMID:
21809010
13.

Immunotherapy in food allergy: towards new strategies.

Sato S, Yanagida N, Ogura K, Asaumi T, Okada Y, Koike Y, Iikura K, Syukuya A, Ebisawa M.

Asian Pac J Allergy Immunol. 2014 Sep;32(3):195-202. Review.

14.

[A case of severe asthma and peach allergy that improved with omalizumab therapy: a case report].

Suzuki S, Matsuura T, Kimura T, Tazaki T, Fukuda M, Homma T, Matsukura S, Kurokawa M, Adachi M.

Arerugi. 2012 Feb;61(2):215-23. Japanese.

PMID:
22437731
15.

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.

Macglashan DW Jr, Saini SS.

J Allergy Clin Immunol. 2013 Oct;132(4):906-11.e1-4. doi: 10.1016/j.jaci.2013.04.056. Epub 2013 Jun 20.

16.

Oral immunotherapy and potential treatment.

Sato S, Yanagida N, Ebisawa M.

Chem Immunol Allergy. 2015;101:106-13. doi: 10.1159/000371697. Epub 2015 May 21.

PMID:
26022870
18.

IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.

Navinés-Ferrer A, Serrano-Candelas E, Molina-Molina GJ, Martín M.

J Immunol Res. 2016;2016:8163803. doi: 10.1155/2016/8163803. Epub 2016 Dec 21. Review.

19.

Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab.

Bell MC, Jackson DJ.

Ann Allergy Asthma Immunol. 2012 May;108(5):383-4. doi: 10.1016/j.anai.2012.02.021. Epub 2012 Mar 21. No abstract available.

20.

Current status of therapy with omalizumab in children.

Baena-Cagnani CE, Gómez RM.

Curr Opin Allergy Clin Immunol. 2014 Apr;14(2):149-54. doi: 10.1097/ACI.0000000000000044. Review.

PMID:
24535142

Supplemental Content

Support Center